BILBOMÁTICA is participating in the LUCIA project (Understanding Lung Cancer-Related Risk Factors and their Impact), which is part of the Horizon Europe Framework Programme ( HORIZON ) call for proposals. This call has received funding under the Research and Innovation actions supporting the implementation of the Mission on Cancer 2022 call . This call supports international collaborations that provide practical technological solutions to current challenges. LUCIA has 22 members.
The project, involving nine European countries, aims to manage lung cancer from the perspective of early diagnosis, prevention, and treatment, particularly of relatively rare lung cancers. The consortium's work will result in recommendations that will be integrated into the early diagnosis program and methods for effectively addressing the disease.
The consortium's objective is to map lung cancer risk factors by focusing on three aspects:
- Individual risk factors, including lifestyle and exposure to pollutants,
- External factors, such as urban or urbanized areas, traffic, climate, and socioeconomic aspects
- Biological responses, such as aging and genetic, epigenetic, and metabolic changes
The Project is led by TECHNION (Israel Institute of Technology) and the participants include the Health organizations of the Basque Health Service Osakidetza (Biocruces), Federation Europeenne des Hôpitaux et des Soins de Sante, Centre Hospitalier Universitaire de Liège and the Andalusian Health Service- SAS.
During the first week of February, all the project partners met at the Technion facilities in Haifa, Israel, for the project kick-off.
More information about the LUCIA project can be found at this link .
The LUCIA project receives funding from the European Union's Horizon Europe research and innovation programme under grant agreement 101096473 .